Valuation (67%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 20.01 | N/A |
| PEG Ratio (TTM) | 8.60 | N/A |
| P/S Ratio (TTM) | 2.53 | N/A |
| P/B Ratio (TTM) | 0.87 | N/A |
| P/FCF Ratio (TTM) | 14.84 | N/A |
| Price to 5YR AVG Earnings Ratio | 23.82 | N/A |
| Price to 5YR AVG FCF Ratio | 21.00 | N/A |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.64% | N/A |
| ROE (TTM) | 4.50% | N/A |
| Net Profit Margin (TTM) | 12.63% | N/A |
| ROIC 5YR AVG | 14.98% | N/A |
Growth (100%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 7.11% | 271.44% | 161.01% |
| Revenue | 6.86% | 32.00% | 17.70% |
| Net Income | 6.62% | 298.05% | 175.75% |
| Cash Flow | 120.88% | 239.50% | 137.27% |
Health (32%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | N/A | N/A |
| Quick Ratio (TTM) | N/A | N/A |
| D/E Ratio (TTM) | 0.46 | N/A |
| Interest Coverage (TTM) | 0.95 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 0.40 | N/A |
| LTL to 5YR AVG FCF | 7.49 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.88% | N/A |